Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Neil A. Hukriede is active.

Publication


Featured researches published by Neil A. Hukriede.


Nature | 2011

Identification of adult nephron progenitors capable of kidney regeneration in zebrafish

Cuong Q. Diep; Dongdong Ma; Rahul C. Deo; Teresa M. Holm; Richard W. Naylor; Natasha Arora; Rebecca A. Wingert; Frank Bollig; Gordana Djordjevic; Benjamin R. Lichman; Hao Zhu; Takanori Ikenaga; Fumihito Ono; Christoph Englert; Chad A. Cowan; Neil A. Hukriede; Robert I. Handin; Alan J. Davidson

Loss of kidney function underlies many renal diseases. Mammals can partly repair their nephrons (the functional units of the kidney), but cannot form new ones. By contrast, fish add nephrons throughout their lifespan and regenerate nephrons de novo after injury, providing a model for understanding how mammalian renal regeneration may be therapeutically activated. Here we trace the source of new nephrons in the adult zebrafish to small cellular aggregates containing nephron progenitors. Transplantation of single aggregates comprising 10–30 cells is sufficient to engraft adults and generate multiple nephrons. Serial transplantation experiments to test self-renewal revealed that nephron progenitors are long-lived and possess significant replicative potential, consistent with stem-cell activity. Transplantation of mixed nephron progenitors tagged with either green or red fluorescent proteins yielded some mosaic nephrons, indicating that multiple nephron progenitors contribute to a single nephron. Consistent with this, live imaging of nephron formation in transparent larvae showed that nephrogenic aggregates form by the coalescence of multiple cells and then differentiate into nephrons. Taken together, these data demonstrate that the zebrafish kidney probably contains self-renewing nephron stem/progenitor cells. The identification of these cells paves the way to isolating or engineering the equivalent cells in mammals and developing novel renal regenerative therapies.


Developmental Dynamics | 2009

Automated image-based phenotypic analysis in zebrafish embryos

Andreas Vogt; Andrzej Cholewinski; Xiaoqiang Shen; Scott G. Nelson; John S. Lazo; Michael Tsang; Neil A. Hukriede

Presently, the zebrafish is the only vertebrate model compatible with contemporary paradigms of drug discovery. Zebrafish embryos are amenable to automation necessary for high‐throughput chemical screens, and optical transparency makes them potentially suited for image‐based screening. However, the lack of tools for automated analysis of complex images presents an obstacle to using the zebrafish as a high‐throughput screening model. We have developed an automated system for imaging and analyzing zebrafish embryos in multi‐well plates regardless of embryo orientation and without user intervention. Images of fluorescent embryos were acquired on a high‐content reader and analyzed using an artificial intelligence‐based image analysis method termed Cognition Network Technology (CNT). CNT reliably detected transgenic fluorescent embryos (Tg(fli1:EGFP)y1) arrayed in 96‐well plates and quantified intersegmental blood vessel development in embryos treated with small molecule inhibitors of anigiogenesis. The results demonstrate it is feasible to adapt image‐based high‐content screening methodology to measure complex whole organism phenotypes. Developmental Dynamics 238:656–663, 2009.


Journal of The American Society of Nephrology | 2013

Histone deacetylase inhibitor enhances recovery after AKI.

Chiara Cianciolo Cosentino; Nataliya I. Skrypnyk; Lauren L. Brilli; Takuto Chiba; Tatiana Novitskaya; Clara Woods; James West; Vasiliy N. Korotchenko; Lee McDermott; Billy W. Day; Alan J. Davidson; Raymond C. Harris; Mark P. de Caestecker; Neil A. Hukriede

At present, there are no effective therapies to ameliorate injury, accelerate recovery, or prevent postinjury fibrosis after AKI. Here, we sought to identify candidate compounds that accelerate recovery after AKI by screening for small molecules that increase proliferation of renal progenitor cells in zebrafish embryos. One compound identified from this screen was the histone deacetylase inhibitor methyl-4-(phenylthio)butanoate, which we subsequently administered to zebrafish larvae and mice 24-48 hours after inducing AKI. In zebrafish, treatment with the compound increased larval survival and proliferation of renal tubular epithelial cells. In mice, treatment accelerated recovery, reduced postinjury tubular atrophy and interstitial fibrosis, and increased the regenerative capacity of actively cycling renal tubular cells by decreasing the number of cells in G2/M arrest. These data suggest that accelerating recovery may be a viable approach to treating AKI and provide proof of concept that a screen in zebrafish embryos can identify therapeutic candidates for kidney injury.


Journal of The American Society of Nephrology | 2010

Inhibition of Histone Deacetylase Expands the Renal Progenitor Cell Population

Eric D. de Groh; Lisa M. Swanhart; Chiara Cianciolo Cosentino; Rachel L. Jackson; Weixiang Dai; Carolyn A. Kitchens; Billy W. Day; Thomas E. Smithgall; Neil A. Hukriede

One of the first hallmarks of kidney regeneration is the reactivation of genes normally required during organogenesis. Identification of chemicals with the potential to enhance this reactivation could therapeutically promote kidney regeneration. Here, we found that 4-(phenylthio)butanoic acid (PTBA) expanded the expression domains of molecular markers of kidney organogenesis in zebrafish. PTBA exhibits structural and functional similarity to the histone deacetylase (HDAC) inhibitors 4-phenylbutanoic acid and trichostatin A; treatment with these HDAC inhibitors also expanded the renal progenitor cell population. Analyses in vitro and in vivo confirmed that PTBA functions as an inhibitor of HDAC activity. Furthermore, PTBA-mediated renal progenitor cell expansion required retinoic acid signaling. In summary, these results support a mechanistic link among renal progenitor cells, HDAC, and the retinoid pathway. Whether PTBA holds promise as a therapeutic agent to promote renal regeneration requires further study.


Nucleic Acids Research | 2007

Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene

Qing Bai; Jessica A. Garver; Neil A. Hukriede; Edward A. Burton

The aim of this study was to isolate cis-acting regulatory elements for the generation of transgenic zebrafish models of neurodegeneration. Zebrafish enolase-2 (eno2) showed neuronal expression increasing from 24 to 72 h post-fertilization (hpf) and persisting through adulthood. A 12 kb eno2 genomic fragment, extending from 8 kb upstream of exon 1 to exon 2, encompassing intron 1, was sufficient to drive neuronal reporter gene expression in vivo over a similar time course. Five independent lines of stable Tg(eno2 : GFP) zebrafish expressed GFP widely in neurons, including populations with relevance to neurodegeneration, such as cholinergic neurons, dopaminergic neurons and cerebellar Purkinje cells. We replaced the exon 2-GFP fusion gene with a cDNA encoding the 4-repeat isoform of the human microtubule-associated protein Tau. The first intron of eno2 was spliced with high fidelity and efficiency from the chimeric eno2-Tau transcript. Tau was expressed at ∼8-fold higher levels in Tg(eno2 : Tau) zebrafish brain than normal human brain, and localized to axons, neuropil and ectopic neuronal somatic accumulations resembling neurofibrillary tangles. The 12 kb eno2 promoter drives high-level transgene expression in differentiated neurons throughout the CNS of stable transgenic zebrafish. This regulatory element will be useful for the construction of transgenic zebrafish models of neurodegeneration.


Proceedings of the National Academy of Sciences of the United States of America | 2002

Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development

Lan Chen; Daniel Segal; Neil A. Hukriede; Alexandre V. Podtelejnikov; Dashzeveg Bayarsaihan; James A. Kennison; Vasily Ogryzko; Igor B. Dawid; Heiner Westphal

The LIM-domain-binding protein Ldb1 is a key factor in the assembly of transcriptional complexes involving LIM-homeodomain proteins and other transcription factors that regulate animal development. We identified Ssdp proteins (previously described as sequence-specific, single-stranded-DNA-binding proteins) as components of Ldb1-associated nuclear complexes in HeLa cells. Ssdp proteins are associated with Ldb1 in a variety of additional mammalian cell types. This association is specific, does not depend on the presence of nucleic acids, and is functionally significant. Genes encoding Ssdp proteins are well conserved in evolution from Drosophila to humans. Whereas the vertebrate Ssdp gene family has several closely related members, the Drosophila Ssdp gene is unique. In Xenopus, Ssdp encoded by Drosophila Ssdp or mouse Ssdp1 mRNA enhances axis induction by Ldb1 in conjunction with the LIM-homeobox gene Xlim1. Furthermore, we were able to demonstrate an interaction between Ssdp and Chip (the fly homolog of Ldb1) in Drosophila wing development. These findings indicate functional conservation of Ssdp as a cofactor of Ldb1 during invertebrate and vertebrate development.


PLOS Biology | 2013

Wdpcp, a PCP Protein Required for Ciliogenesis, Regulates Directional Cell Migration and Cell Polarity by Direct Modulation of the Actin Cytoskeleton

Cheng Cui; Bishwanath Chatterjee; Thomas P. Lozito; Zhen Zhang; Richard Francis; Hisato Yagi; Lisa M. Swanhart; Subramaniam Sanker; Deanne Francis; Qing Yu; Jovenal T. San Agustin; Chandrakala Puligilla; Tania Chatterjee; Terry Tansey; Xiaoqin Liu; Matthew W. Kelley; Elias T. Spiliotis; Adam V. Kwiatkowski; Rocky S. Tuan; Gregory J. Pazour; Neil A. Hukriede; Cecilia W. Lo

Wdpcp, a protein required for both planar cell polarity and ciliogenesis, regulates cell polarity and alignment via direct modulation of the actin cytoskeleton.


Journal of Visualized Experiments | 2010

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury

Chiara Cianciolo Cosentino; Beth L. Roman; Iain A. Drummond; Neil A. Hukriede

In this video article we describe a zebrafish model of AKI using gentamicin as the nephrotoxicant. The technique consists of intravenous microinjections on 2 dpf zebrafish. This technique represents an efficient and rapid method to deliver soluble substances into the bloodstream of zebrafish larvae, allowing for the injection of 15-20 fish per hour. In addition to AKI studies, this microinjection technique can also be used for other types of experimental studies such as angiography. We provide a detailed protocol of the technique from equipment required to visual measures of decreased kidney function. In addition, we also demonstrate the process of fixation, whole mount immunohistochemistry with a kidney tubule marker, plastic embedding and sectioning of the larval zebrafish. We demonstrate that zebrafish larvae injected with gentamicin show morphological features consistent with AKI: edema, loss of cell polarity in proximal tubular epithelial cells, and morphological disruption of the tubule.


Traffic | 2012

OCRL1 Modulates Cilia Length in Renal Epithelial Cells

Youssef Rbaibi; Shanshan Cui; Di Mo; Marcelo D. Carattino; Rajeev Rohatgi; Lisa M. Satlin; Christina M. Szalinski; Lisa M. Swanhart; Heike Fölsch; Neil A. Hukriede; Ora A. Weisz

Lowe syndrome is an X‐linked disorder characterized by cataracts at birth, mental retardation and progressive renal malfunction that results from loss of function of the OCRL1 (oculocerebrorenal syndrome of Lowe) protein. OCRL1 is a lipid phosphatase that converts phosphatidylinositol 4,5‐bisphosphate to phosphatidylinositol 4‐phosphate. The renal pathogenesis of Lowe syndrome patients has been suggested to result from alterations in membrane trafficking, but this cannot fully explain the disease progression. We found that knockdown of OCRL1 in zebrafish caused developmental defects consistent with disruption of ciliary function, including body axis curvature, pericardial edema, hydrocephaly and impaired renal clearance. In addition, cilia in the proximal tubule of the zebrafish pronephric kidney were longer in ocrl morphant embryos. We also found that knockdown of OCRL1 in polarized renal epithelial cells caused elongation of the primary cilium and disrupted formation of cysts in three‐dimensional cultures. Calcium release in response to ATP was blunted in OCRL1 knockdown cells, suggesting changes in signaling that could lead to altered cell function. Our results suggest a new role for OCRL1 in renal epithelial cell function that could contribute to the pathogenesis of Lowe syndrome.


Birth Defects Research Part C-embryo Today-reviews | 2011

Zebrafish kidney development: Basic science to translational research

Lisa M. Swanhart; Chiara Cianciolo Cosentino; Cuong Q. Diep; Alan J. Davidson; Mark P. de Caestecker; Neil A. Hukriede

The zebrafish has become a significant model system for studying renal organogenesis and disease, as well as for the quest for new therapeutics, because of the structural and functional simplicity of the embryonic kidney. Inroads to the nature and disease states of kidney-related ciliopathies and acute kidney injury (AKI) have been advanced by zebrafish studies. This model organism has been instrumental in the analysis of mutant gene function for human disease with respect to ciliopathies. Additionally, in the AKI field, recent work in the zebrafish has identified a bona fide adult zebrafish renal progenitor (stem) cell that is required for neo-nephrogenesis, both during the normal lifespan and in response to renal injury. Taken together, these studies solidify the zebrafish as a successful model system for studying the broad spectrum of ciliopathies and AKI that affect millions of humans worldwide, and point to a very promising future of zebrafish drug discovery. The emphasis of this review will be on the role of the zebrafish as a model for human kidney-related ciliopathies and AKI, and how our understanding of these complex pathologies is being furthered by this tiny teleost.

Collaboration


Dive into the Neil A. Hukriede's collaboration.

Top Co-Authors

Avatar

Igor B. Dawid

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mark P. de Caestecker

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Andreas Vogt

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Billy W. Day

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge